Assessing the clinical utility of prescription EPA - What do the latest data suggest?

3 September 2019 (16:10 - 16:17)
Organised by:
Congress Presentation Part of: Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice Risk Factors and Prevention, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo

Medstar Research Institute, Washington, DC (United States of America)

4 More presentations in this session

The Event

Event poster

ESC Congress 2019

3 September 2019 16:10 CET